Clinical Trials Directory

Trials / Conditions / Advanced Colorectal Carcinoma

Advanced Colorectal Carcinoma

24 registered clinical trials studyying Advanced Colorectal Carcinoma — 11 currently recruiting.

StatusTrialSponsorPhase
RecruitingEngage Psychosocial Intervention for Cancer Symptoms
NCT06555588
Duke UniversityN/A
RecruitingPhase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanc
NCT06521866
Fudan UniversityPhase 2
Not Yet RecruitingMolecular Study and Precision Medicine for Colorectal Cancer
NCT05883683
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology—
RecruitingLOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
NCT06073431
University of Rochester—
TerminatedFirst-line Maintenance of OH2 Injection for Advanced Colorectal Cancer
NCT05648006
Binhui Biopharmaceutical Co., Ltd.Phase 2
RecruitingSurvival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer
NCT05894694
Guang'anmen Hospital of China Academy of Chinese Medical SciencesPhase 4
RecruitingAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
NCT05969860
Mayo ClinicPhase 2
RecruitingThe Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor C
NCT05967533
University of California, DavisPhase 1
RecruitingCPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Pati
NCT05733000
Northwestern UniversityPhase 2
RecruitingFirst-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patien
NCT05759923
Molecure S.A.Phase 1
RecruitingA Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer
NCT05200442
University of ChicagoPhase 1 / Phase 2
UnknownHepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line
NCT05406206
Peking University Cancer Hospital & InstitutePhase 2
Active Not RecruitingTesting the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or
NCT04535401
National Cancer Institute (NCI)Phase 1
RecruitingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tu
NCT04704661
National Cancer Institute (NCI)Phase 1
CompletedCombining Epigenetic And Immune Therapy to Beat Cancer.
NCT04705818
Institut BergoniéPhase 2
TerminatedA Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesio
NCT04645797
Apros Therapeutics, IncPhase 1
UnknownFruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer
NCT04582981
Fudan UniversityPhase 2
CompletedDasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Ca
NCT04164069
Anne NoonanPhase 1
CompletedTAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Ca
NCT04109924
Roswell Park Cancer InstitutePhase 2
UnknownRegorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer
NCT04771715
Peking Union Medical College Hospital—
Active Not RecruitingDanvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung C
NCT02983578
M.D. Anderson Cancer CenterPhase 2
Completed4SC-201 (Resminostat) in Advanced Colorectal Carcinoma
NCT01277406
4SC AGPhase 1 / Phase 2
CompletedEfficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carc
NCT01208194
Mologen AGPhase 2
CompletedPhase I FOLFOX Combination
NCT00499850
Genzyme, a Sanofi CompanyPhase 1